Clinical Trials Sponsored by JLM Innovation GmbH

Total 133 results

University of Ulm
Medac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)

Completed

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

Rectal Cancer

Germany
Heidelberg University
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Completed

A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis (LEOMEX)

Primary Amyloidosis

Germany
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Acquired Hemophilia A

United States, Italy, United Kingdom, Germany, Austria, Netherlands, France
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Terminated

BAX 802 in CHA With Inhibitors (CHAWI)

Hemophilia A

Netherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

Acquired Hemophilia A

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Hemophilia A

United States, Belgium, France, Norway, Netherlands, Austria, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Sweden
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) (AHEAD)

Hemophilia A

Czechia, Switzerland, Denmark, Canada, Australia, Austria, France, United Kingdom, Italy, Sweden, Belgium, Brazil, China, Colombia, Greece, Hungary, Norway, Poland, Portugal, Russian Federation, Slovenia, Spain
Takeda
Takeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...

Completed

A Study of TAK-881 in Healthy Adults

Healthy Volunteers

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants

Healthy Volunteers

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)

Hemophilia A or B With Inhibitors

Croatia, North Macedonia, Ukraine
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

RIXUBIS PMS India (RIXUBIS PMS)

Hemophilia B

India
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Exposure During Pregnancy

Poland, Czechia, United States, Germany, Slovakia
Albert Christian Ludolph, Prof.
Nutritia GmbH, 91052 Erlangen, Germany

Completed

Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS) (TOLCAL)

Amyotrophic Lateral Sclerosis

Germany
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

BAX 855 PK-guided Dosing (PROPEL)

Hemophilia A

Spain, United States, Australia, Singapore, Taiwan, Hong Kong, Malaysia, Bulgaria, United Kingdom, Switzerland, Ukraine, Turkey, Italy, Norway, France, Austria, Romania, Sweden, Poland, Germany, Hungary, Israel
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

BAX 855 Continuation

Hemophilia A

United States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Taiwan, Poland, Bulgaria, United Kingdom, Germany, Turkey, Israel, Malaysia, Ukraine, Russian Federation, Austria, Switzerland, Japan, Hong Kong, Lithuania, Roman... and more
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Terminated

Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

Chronic Obstructive Pulmonary Disease | Alpha1-antitrypsin Deficiency

United States, Canada, Australia
Jacobs University Bremen gGmbH
Goethe University; University Hospital Ulm; Techniker Krankenkasse; German Coalition... and other collaborators

Completed

TeamBaby - Safe, Digitally Supported Communication in Obstetrics and Gynecology (TeamBaby)

Pregnancy Related

Germany
National Cancer Institute, Naples
Immatics Biotechnologies GmbH; CureVac; European Commission -FP7-Health-2013-Innovation-1

Completed

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

Belgium, Germany, Italy, Spain, United Kingdom
University of Ulm
GlaxoSmithKline; WiSP Wissenschaftlicher Service Pharma GmbH; German CLL Study...

Terminated

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Thrombocytopenia | Chronic Lymphocytic Leukemia

Austria, Germany
Christian Buske
Roche Pharma AG; University of Ulm; Zentrum für Klinische Studien Ulm; X-act Cologne... and other collaborators

Active, not recruiting

Obinutuzumab in Marginal Zone Lymphoma

Marginal Zone Lymphoma

Germany
University of Wuerzburg
medac GmbH; Hiege-Stiftung gegen Hautkrebs; DCS Innovative Diagnostik Systeme

Unknown

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC (ChemoSensMM)

Melanoma

Germany
University of Latvia
Uppsala University; Pontificia Universidad Catolica de Chile; Technion, Israel... and other collaborators

Recruiting

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach (VOGAS)

Gastric Cancer | Gastric Dysplasia | Atrophic Gastritis | H.Pylori Infection

Brazil, Chile, Colombia, Latvia, Ukraine
University of Ulm
Merck Sharp & Dohme LLC; Zentrum für Klinische Studien Ulm; X-act Cologne Clinical... and other collaborators

Recruiting

Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY

Marginal Zone Lymphoma

Austria, Germany
Christian Buske
Bayer; University of Ulm; Zentrum für Klinische Studien Ulm; X-act Cologne Clinical... and other collaborators

Active, not recruiting

Copanlisib and Rituximab in Marginal Zone Lymphoma Patients

Marginal Zone Lymphoma

Germany, Austria
University of Latvia
Karolinska Institutet; Lithuanian University of Health Sciences; Technion, Israel... and other collaborators

Completed

Volatile Markers in Digestive Cancer (VOLGACORE)

Gastric Cancer | Colorectal Cancer | Colorectal Adenoma | Intestinal Metaplasia | Atrophic Gastritis | H.Pylori Infection | Peptic Ulcer Disease | Normal Control | Average-risk General Population

Latvia, Lithuania
Prof. W. Janni
Roche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbH

Recruiting

Detect V / CHEVENDO (Chemo vs. Endo)

Metastatic Breast Cancer

Germany
University Medical Center Rostock
Techniker Krankenkasse; AOK Nordwest; Philips GmbH Market DACH; AMEDON GmbH; Lohfert... and other collaborators

Unknown

Investigation of a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease (CardioCare MV)

Heart Failure | Atrial Fibrillation | Treatment Resistant Hypertension

Germany
Heinrich-Heine University, Duesseldorf
Philips GmbH, Innovative Technologies, Aachen; Klinik für Unfall - und Handchirurgie...

Completed

Acute Effects of Whole Body Blue Light Exposure on Blood Pressure

Blue Light

Germany
University of Ulm
Technical University of Munich; WiSP Wissenschaftlicher Service Pharma GmbH; German...

Completed

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

Chronic Lymphocytic Leukemia

France, Austria, Germany
University of Ulm
Sanofi; Assign Data Management and Biostatistics GmbH; Hubertus-Wald-Cancer Center...

Unknown

PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer (PERMAD)

Metastatic Colorectal Cancer

Germany
Institut für Diabetes-Technologie Forschungs- und...

Completed

Assessment of Glucose Concentrations in People Without Diabetes Mellitus After Standardized Meals and in Daily Life

Subjects Without Diabetes Mellitus | Assessment of Glucose Concentrations

Germany
Institut für Diabetes-Technologie Forschungs- und...

Completed

Institut Fuer Diabetes-Technologie Surveillance Program

Diabetes

Germany
Institut für Diabetes-Technologie Forschungs- und...

Completed

System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System

Diabetes

Germany
Baxalta now part of Shire
Takeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...

Active, not recruiting

A Study of BAX 888 in Male Adults With Severe Hemophilia A

Hemophilia A

United States, Spain, Hungary, Italy, Germany, Austria, France
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; Mach Gaensslen Foundation; Baxalta Innovations...

Recruiting

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) (TTP registry)

Thrombotic Thrombocytopenic Purpura | Congenital Thrombotic Thrombocytopenic Purpura | Familial Thrombotic Thrombocytopenic Purpura | Thrombotic Thrombocytopenic Purpura, Congenital | Upshaw-Schulman Syndrome

United States, Austria, Czechia, Germany, Japan, Norway, Switzerland
ConvaTec Inc.
ClinSearch; Welsh Wound Innovation Centre; Qualizyme Diagnostics GmbH & Co KG; Perfectus... and other collaborators

Withdrawn

Analytical Performance of pH, HNE and MPO Levels in Detecting Wound Infection Proof of Concept Biomarker Study (INDICATE)

Wound Infection | Wound Heal
Tillotts Pharma AG
University Hospital, Basel, Switzerland; University of Basel; SocraTec R&D GmbH; Swiss Commission for Technology and Innovation

Completed

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

Healthy

Switzerland
Universitätsklinikum Hamburg-Eppendorf
Charite University, Berlin, Germany; University Hospital Ulm; University Medical...

Active, not recruiting

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Oropharyngeal Cancer

Germany
Oviva AG
Bern University of Applied Sciences; Swiss Commission for Technology and Innovation and other collaborators

Completed

Weight-loss Treatment Through Smartphone-assisted Dietary Coaching (Oviva)

Obesity | Overweight

Switzerland
Institut für Diabetes-Technologie Forschungs- und...
Bayer

Completed

User Performance Evaluation of Contour Plus, Accu-Chek Active, Accu-Chek Performa and OneTouch Select Simple Blood Glucose Monitoring Systems Following ISO 15197:2013

Diabetes

Germany
Institut für Diabetes-Technologie Forschungs- und...
Sanofi

Completed

Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus

Diabetes

Germany
Medical Valley Digital Health Application Center...
Philipps University Marburg Medical Center; University Hospital Erlangen; University... and other collaborators

Completed

Digital GaitCare - Therapy Monitoring in the Home Environment of Patients With Parkinson

Parkinson Disease | Gait Disorders, Neurologic

Germany
Institut für Diabetes-Technologie Forschungs- und...
LifeScan

Completed

Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS)

Diabetes Mellitus

Germany
Institut für Diabetes-Technologie Forschungs- und...
Bayer

Completed

System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013

Diabetes

Germany
Institut für Diabetes-Technologie Forschungs- und...
Bayer

Completed

System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013

Diabetes

Germany
Institut für Diabetes-Technologie Forschungs- und...
Sanofi

Completed

Assessment of Blood Glucose Monitoring Systems

Diabetes

Germany
Institut für Diabetes-Technologie Forschungs- und...
Bayer

Completed

Analytical Performance Evaluation of Blood Glucose Monitoring Systems- Investigator Sponsored Contour® XT Comparator Study - Ulm Germany (IDT-1206-BA)

Diabetes

Germany

Clinical Trials Sponsored by JLM Innovation GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations